A Phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus para-aortic irradiation for stage III/IV endometrial carcinoma
Phase of Trial: Phase II
Latest Information Update: 25 Oct 2013
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 07 Sep 2006 New trial record.